| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Eclampsia | 11 | 2024 | 268 | 3.190 |
Why?
|
| Hypertension, Pregnancy-Induced | 7 | 2024 | 85 | 2.280 |
Why?
|
| Activins | 4 | 2022 | 26 | 2.080 |
Why?
|
| Cardiomyopathies | 9 | 2024 | 318 | 1.880 |
Why?
|
| Postpartum Period | 6 | 2025 | 163 | 1.710 |
Why?
|
| Patient Readmission | 4 | 2019 | 413 | 1.680 |
Why?
|
| Echocardiography | 13 | 2021 | 1010 | 1.600 |
Why?
|
| Ventricular Function, Left | 4 | 2022 | 677 | 1.410 |
Why?
|
| Heart Diseases | 5 | 2024 | 318 | 1.370 |
Why?
|
| Pregnancy | 25 | 2025 | 3239 | 1.340 |
Why?
|
| Sepsis | 5 | 2018 | 389 | 1.290 |
Why?
|
| Heart Ventricles | 4 | 2021 | 826 | 1.170 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2017 | 111 | 1.100 |
Why?
|
| Follistatin-Related Proteins | 2 | 2025 | 11 | 1.060 |
Why?
|
| Perioperative Care | 7 | 2022 | 188 | 1.060 |
Why?
|
| Puerperal Disorders | 2 | 2025 | 37 | 0.990 |
Why?
|
| Blood Pressure | 4 | 2018 | 926 | 0.920 |
Why?
|
| Anesthesiology | 8 | 2022 | 168 | 0.900 |
Why?
|
| Opioid-Related Disorders | 2 | 2019 | 233 | 0.870 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2019 | 346 | 0.870 |
Why?
|
| Shock, Cardiogenic | 3 | 2018 | 172 | 0.850 |
Why?
|
| Peripartum Period | 3 | 2024 | 29 | 0.800 |
Why?
|
| Biomedical Research | 2 | 2018 | 442 | 0.760 |
Why?
|
| Humans | 78 | 2025 | 95992 | 0.740 |
Why?
|
| Stroke Volume | 3 | 2022 | 550 | 0.740 |
Why?
|
| Hypertension | 5 | 2024 | 775 | 0.700 |
Why?
|
| Critical Care | 4 | 2020 | 448 | 0.700 |
Why?
|
| Biomarkers | 8 | 2025 | 1931 | 0.700 |
Why?
|
| Shock, Septic | 4 | 2018 | 125 | 0.690 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 778 | 0.660 |
Why?
|
| Female | 41 | 2025 | 49980 | 0.660 |
Why?
|
| Adult | 30 | 2025 | 28636 | 0.650 |
Why?
|
| Retrospective Studies | 20 | 2024 | 10307 | 0.650 |
Why?
|
| Prospective Studies | 17 | 2024 | 4690 | 0.650 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 4 | 2018 | 105 | 0.650 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 1982 | 0.640 |
Why?
|
| Inpatients | 2 | 2020 | 348 | 0.630 |
Why?
|
| Decision Support Techniques | 2 | 2021 | 186 | 0.620 |
Why?
|
| Myocardial Contraction | 1 | 2021 | 253 | 0.620 |
Why?
|
| Prenatal Care | 1 | 2020 | 84 | 0.610 |
Why?
|
| Length of Stay | 4 | 2018 | 835 | 0.600 |
Why?
|
| Aspirin | 1 | 2020 | 169 | 0.590 |
Why?
|
| Palpation | 1 | 2018 | 19 | 0.580 |
Why?
|
| Critical Illness | 2 | 2019 | 346 | 0.570 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 205 | 0.530 |
Why?
|
| Publication Bias | 1 | 2017 | 18 | 0.530 |
Why?
|
| Pregnancy Complications | 3 | 2017 | 355 | 0.530 |
Why?
|
| Fluid Therapy | 1 | 2018 | 67 | 0.530 |
Why?
|
| Editorial Policies | 1 | 2017 | 33 | 0.520 |
Why?
|
| Lung Injury | 1 | 2018 | 60 | 0.520 |
Why?
|
| Endoglin | 1 | 2017 | 21 | 0.520 |
Why?
|
| Biostatistics | 1 | 2017 | 21 | 0.510 |
Why?
|
| Aortic Aneurysm | 1 | 2017 | 82 | 0.510 |
Why?
|
| Blood Loss, Surgical | 1 | 2017 | 133 | 0.500 |
Why?
|
| Pain, Postoperative | 2 | 2019 | 277 | 0.490 |
Why?
|
| Blood Transfusion | 1 | 2017 | 180 | 0.490 |
Why?
|
| Evidence-Based Medicine | 2 | 2021 | 458 | 0.490 |
Why?
|
| Echocardiography, Three-Dimensional | 5 | 2015 | 528 | 0.480 |
Why?
|
| Databases, Factual | 5 | 2018 | 1014 | 0.480 |
Why?
|
| Angiogenic Proteins | 1 | 2016 | 17 | 0.480 |
Why?
|
| Hospital Mortality | 2 | 2018 | 485 | 0.480 |
Why?
|
| Young Adult | 11 | 2020 | 7034 | 0.460 |
Why?
|
| Pharmacogenetics | 5 | 2022 | 457 | 0.450 |
Why?
|
| Pharmacogenomic Testing | 3 | 2021 | 107 | 0.450 |
Why?
|
| Heart | 3 | 2017 | 596 | 0.440 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2017 | 239 | 0.440 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 935 | 0.440 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 43 | 0.430 |
Why?
|
| Pregnancy Outcome | 4 | 2018 | 273 | 0.420 |
Why?
|
| Research Design | 1 | 2018 | 630 | 0.420 |
Why?
|
| Echocardiography, Transesophageal | 7 | 2018 | 364 | 0.420 |
Why?
|
| Risk Factors | 10 | 2021 | 5992 | 0.400 |
Why?
|
| Aortic Valve Stenosis | 2 | 2012 | 169 | 0.400 |
Why?
|
| Hospitals | 2 | 2021 | 329 | 0.390 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 334 | 0.390 |
Why?
|
| Heart Failure | 2 | 2024 | 1438 | 0.380 |
Why?
|
| Hospitalization | 2 | 2015 | 946 | 0.360 |
Why?
|
| Heart-Assist Devices | 1 | 2019 | 903 | 0.350 |
Why?
|
| Anesthesia | 3 | 2022 | 175 | 0.330 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1962 | 0.330 |
Why?
|
| Adolescent | 9 | 2018 | 9878 | 0.330 |
Why?
|
| Aged, 80 and over | 8 | 2018 | 7224 | 0.320 |
Why?
|
| Aged | 16 | 2019 | 20927 | 0.320 |
Why?
|
| Cardiac Surgical Procedures | 5 | 2018 | 519 | 0.310 |
Why?
|
| Cohort Studies | 6 | 2018 | 3115 | 0.300 |
Why?
|
| Image Enhancement | 1 | 2012 | 565 | 0.300 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 1018 | 0.290 |
Why?
|
| United States | 7 | 2019 | 7785 | 0.290 |
Why?
|
| Treatment Outcome | 8 | 2022 | 9228 | 0.290 |
Why?
|
| Middle Aged | 14 | 2019 | 28299 | 0.270 |
Why?
|
| Internship and Residency | 5 | 2019 | 1134 | 0.260 |
Why?
|
| Operating Rooms | 2 | 2019 | 138 | 0.260 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2019 | 92 | 0.250 |
Why?
|
| Time Factors | 3 | 2021 | 5593 | 0.250 |
Why?
|
| Vasoconstrictor Agents | 2 | 2017 | 68 | 0.240 |
Why?
|
| Male | 20 | 2022 | 45792 | 0.240 |
Why?
|
| Logistic Models | 4 | 2017 | 1273 | 0.240 |
Why?
|
| Postnatal Care | 3 | 2024 | 31 | 0.230 |
Why?
|
| Predictive Value of Tests | 4 | 2021 | 1819 | 0.230 |
Why?
|
| Clinical Competence | 4 | 2016 | 858 | 0.230 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2011 | 210 | 0.220 |
Why?
|
| Intensive Care Units | 2 | 2019 | 460 | 0.220 |
Why?
|
| Curriculum | 3 | 2019 | 616 | 0.220 |
Why?
|
| Communication | 2 | 2019 | 478 | 0.210 |
Why?
|
| Labor, Obstetric | 2 | 2022 | 48 | 0.210 |
Why?
|
| Placenta | 2 | 2024 | 191 | 0.210 |
Why?
|
| Anesthetics, Inhalation | 1 | 2024 | 102 | 0.200 |
Why?
|
| Occupational Exposure | 1 | 2024 | 89 | 0.190 |
Why?
|
| Cesarean Section | 3 | 2018 | 158 | 0.190 |
Why?
|
| Sex Work | 1 | 2002 | 12 | 0.190 |
Why?
|
| Preoperative Care | 2 | 2017 | 419 | 0.190 |
Why?
|
| Prognosis | 4 | 2021 | 3993 | 0.180 |
Why?
|
| Postoperative Complications | 5 | 2020 | 2603 | 0.180 |
Why?
|
| Monitoring, Intraoperative | 3 | 2018 | 116 | 0.180 |
Why?
|
| Tramadol | 1 | 2022 | 14 | 0.180 |
Why?
|
| Analgesia, Obstetrical | 1 | 2022 | 24 | 0.180 |
Why?
|
| Analgesia, Epidural | 1 | 2022 | 42 | 0.180 |
Why?
|
| Breast Feeding | 2 | 2002 | 108 | 0.170 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 3922 | 0.170 |
Why?
|
| Mitral Valve | 3 | 2012 | 280 | 0.170 |
Why?
|
| Airway Management | 1 | 2022 | 48 | 0.170 |
Why?
|
| Respiratory System | 1 | 2022 | 120 | 0.170 |
Why?
|
| Pharmacogenomic Variants | 1 | 2021 | 45 | 0.170 |
Why?
|
| Anesthetics | 1 | 2021 | 56 | 0.170 |
Why?
|
| Workload | 1 | 2021 | 133 | 0.160 |
Why?
|
| Follistatin | 1 | 2020 | 7 | 0.160 |
Why?
|
| Intubation, Intratracheal | 1 | 2022 | 161 | 0.160 |
Why?
|
| Placenta Growth Factor | 2 | 2018 | 81 | 0.160 |
Why?
|
| Analgesics | 1 | 2021 | 132 | 0.160 |
Why?
|
| Seasons | 1 | 2021 | 246 | 0.160 |
Why?
|
| Elective Surgical Procedures | 1 | 2021 | 164 | 0.160 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2019 | 8 | 0.150 |
Why?
|
| Incidence | 3 | 2018 | 1723 | 0.150 |
Why?
|
| Transportation of Patients | 1 | 2019 | 35 | 0.150 |
Why?
|
| Clinical Decision-Making | 2 | 2021 | 296 | 0.150 |
Why?
|
| Workflow | 1 | 2019 | 80 | 0.150 |
Why?
|
| Pneumonia, Aspiration | 1 | 2018 | 21 | 0.140 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 348 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 2885 | 0.140 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2018 | 28 | 0.140 |
Why?
|
| Hepatitis C Antibodies | 1 | 1998 | 8 | 0.140 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 857 | 0.140 |
Why?
|
| Neuromuscular Blockade | 1 | 2018 | 29 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2020 | 526 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 2 | 2016 | 126 | 0.140 |
Why?
|
| Carrier State | 1 | 1998 | 40 | 0.140 |
Why?
|
| Rats | 2 | 2022 | 4155 | 0.140 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1998 | 45 | 0.140 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2018 | 71 | 0.140 |
Why?
|
| Intraoperative Care | 1 | 2018 | 89 | 0.140 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 123 | 0.140 |
Why?
|
| Oxytocics | 1 | 2018 | 25 | 0.140 |
Why?
|
| Leukocytosis | 1 | 2017 | 15 | 0.130 |
Why?
|
| Maternal Health Services | 1 | 2017 | 16 | 0.130 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2017 | 71 | 0.130 |
Why?
|
| Pain Management | 1 | 2019 | 180 | 0.130 |
Why?
|
| Cystectomy | 1 | 2018 | 114 | 0.130 |
Why?
|
| Hospital Costs | 1 | 2018 | 117 | 0.130 |
Why?
|
| Oxytocin | 1 | 2018 | 75 | 0.130 |
Why?
|
| Heart Rate | 2 | 2017 | 533 | 0.130 |
Why?
|
| Maternal Mortality | 1 | 2017 | 15 | 0.130 |
Why?
|
| Prevalence | 2 | 2018 | 1355 | 0.130 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 209 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2022 | 395 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 365 | 0.130 |
Why?
|
| Bradycardia | 1 | 2017 | 47 | 0.130 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2017 | 155 | 0.120 |
Why?
|
| Hepatitis C | 1 | 1998 | 184 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2017 | 239 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 2042 | 0.120 |
Why?
|
| Protamines | 1 | 2015 | 8 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2018 | 747 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2017 | 721 | 0.120 |
Why?
|
| Hemodynamics | 2 | 2018 | 776 | 0.120 |
Why?
|
| Robotic Surgical Procedures | 1 | 2022 | 367 | 0.120 |
Why?
|
| Infant, Newborn | 3 | 2012 | 2611 | 0.110 |
Why?
|
| Child | 2 | 2020 | 7621 | 0.110 |
Why?
|
| Computer Simulation | 4 | 2016 | 1158 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 380 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 346 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 334 | 0.110 |
Why?
|
| Gestational Age | 1 | 2016 | 343 | 0.110 |
Why?
|
| Comorbidity | 1 | 2018 | 1017 | 0.110 |
Why?
|
| Coronary Artery Bypass | 2 | 2022 | 252 | 0.110 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 64 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2018 | 936 | 0.100 |
Why?
|
| Thoracic Surgery | 1 | 2015 | 62 | 0.100 |
Why?
|
| Demography | 1 | 2014 | 190 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2021 | 2498 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2017 | 1541 | 0.100 |
Why?
|
| HIV Infections | 1 | 2002 | 974 | 0.100 |
Why?
|
| Learning | 1 | 2016 | 305 | 0.100 |
Why?
|
| User-Computer Interface | 2 | 2011 | 196 | 0.100 |
Why?
|
| Neuropeptide Y | 1 | 2012 | 31 | 0.090 |
Why?
|
| Chicago | 3 | 2024 | 1505 | 0.090 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2012 | 30 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2011 | 199 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2015 | 308 | 0.090 |
Why?
|
| Coronary Circulation | 1 | 2012 | 133 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 422 | 0.090 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2012 | 43 | 0.090 |
Why?
|
| Hypercholesterolemia | 1 | 2012 | 161 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2015 | 313 | 0.090 |
Why?
|
| Animals | 6 | 2024 | 28901 | 0.090 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 54 | 0.090 |
Why?
|
| Tricuspid Valve Stenosis | 1 | 2011 | 4 | 0.090 |
Why?
|
| Myocardial Ischemia | 1 | 2012 | 167 | 0.080 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2011 | 23 | 0.080 |
Why?
|
| Saphenous Vein | 1 | 2011 | 61 | 0.080 |
Why?
|
| Succinylcholine | 2 | 2022 | 14 | 0.080 |
Why?
|
| Aneurysm, False | 1 | 2011 | 55 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2012 | 240 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 354 | 0.080 |
Why?
|
| ROC Curve | 1 | 2012 | 799 | 0.080 |
Why?
|
| Water-Electrolyte Balance | 1 | 2010 | 70 | 0.080 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 341 | 0.080 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2024 | 162 | 0.080 |
Why?
|
| Coronary Disease | 1 | 2011 | 263 | 0.080 |
Why?
|
| Teaching | 1 | 2010 | 154 | 0.070 |
Why?
|
| Aortic Valve | 1 | 2011 | 277 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 436 | 0.060 |
Why?
|
| Point-of-Care Systems | 2 | 2019 | 156 | 0.060 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2024 | 36 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2024 | 69 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 2534 | 0.050 |
Why?
|
| Fetal Distress | 1 | 2002 | 11 | 0.050 |
Why?
|
| Infant Welfare | 1 | 2002 | 6 | 0.050 |
Why?
|
| Perfusion | 1 | 2024 | 266 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 2860 | 0.050 |
Why?
|
| Omeprazole | 1 | 2022 | 11 | 0.050 |
Why?
|
| Hydralazine | 1 | 2022 | 21 | 0.050 |
Why?
|
| Electrocardiography | 2 | 2018 | 559 | 0.050 |
Why?
|
| Oxycodone | 1 | 2022 | 35 | 0.040 |
Why?
|
| Bupivacaine | 1 | 2022 | 48 | 0.040 |
Why?
|
| Florida | 1 | 2021 | 63 | 0.040 |
Why?
|
| HIV-1 | 1 | 2002 | 182 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2777 | 0.040 |
Why?
|
| Texas | 1 | 2021 | 131 | 0.040 |
Why?
|
| Telemedicine | 1 | 2024 | 229 | 0.040 |
Why?
|
| Fentanyl | 1 | 2022 | 87 | 0.040 |
Why?
|
| Age Distribution | 1 | 2021 | 210 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2024 | 1729 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2021 | 51 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 2022 | 84 | 0.040 |
Why?
|
| Fever | 1 | 2022 | 131 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2021 | 115 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2012 | 1319 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2021 | 164 | 0.040 |
Why?
|
| Washington | 1 | 2020 | 51 | 0.040 |
Why?
|
| New York City | 1 | 2020 | 69 | 0.040 |
Why?
|
| Coronary Angiography | 2 | 2012 | 262 | 0.040 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 33 | 0.040 |
Why?
|
| Personnel, Hospital | 1 | 2020 | 32 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2021 | 182 | 0.040 |
Why?
|
| Laboratories | 1 | 2020 | 48 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 79 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2024 | 502 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2019 | 52 | 0.040 |
Why?
|
| Health Resources | 1 | 2020 | 82 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 426 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 675 | 0.040 |
Why?
|
| Atracurium | 1 | 2018 | 5 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 481 | 0.040 |
Why?
|
| Colostrum | 1 | 1998 | 2 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2021 | 221 | 0.040 |
Why?
|
| Milk, Human | 1 | 1998 | 51 | 0.030 |
Why?
|
| Fetal Blood | 1 | 1998 | 95 | 0.030 |
Why?
|
| Organ Dysfunction Scores | 1 | 2018 | 34 | 0.030 |
Why?
|
| Uterus | 1 | 2019 | 228 | 0.030 |
Why?
|
| Simulation Training | 1 | 2019 | 108 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1176 | 0.030 |
Why?
|
| Ischemia | 1 | 2019 | 256 | 0.030 |
Why?
|
| Therapeutics | 1 | 2017 | 13 | 0.030 |
Why?
|
| Hepacivirus | 1 | 1998 | 137 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2017 | 217 | 0.030 |
Why?
|
| RNA, Viral | 1 | 1998 | 311 | 0.030 |
Why?
|
| Pneumonia | 1 | 2018 | 196 | 0.030 |
Why?
|
| Perinatal Care | 1 | 2017 | 23 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1267 | 0.030 |
Why?
|
| APACHE | 1 | 2016 | 24 | 0.030 |
Why?
|
| Software | 2 | 2011 | 698 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 1618 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 162 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 233 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1998 | 897 | 0.030 |
Why?
|
| Propensity Score | 1 | 2017 | 179 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2018 | 288 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 640 | 0.030 |
Why?
|
| Pregnancy Proteins | 1 | 2015 | 37 | 0.030 |
Why?
|
| Pregnancy in Diabetics | 1 | 2015 | 41 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2019 | 566 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 12525 | 0.030 |
Why?
|
| Diabetes, Gestational | 1 | 2015 | 49 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2019 | 456 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2015 | 93 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2015 | 136 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 683 | 0.030 |
Why?
|
| Aorta | 1 | 2015 | 294 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 880 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1966 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 647 | 0.030 |
Why?
|
| Consensus | 1 | 2015 | 372 | 0.020 |
Why?
|
| Echocardiography, Four-Dimensional | 1 | 2012 | 1 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2015 | 246 | 0.020 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2012 | 3 | 0.020 |
Why?
|
| Bromocriptine | 1 | 2012 | 12 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2012 | 18 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 438 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2011 | 43 | 0.020 |
Why?
|
| Infant | 1 | 1998 | 3359 | 0.020 |
Why?
|
| Systole | 1 | 2011 | 118 | 0.020 |
Why?
|
| Ventricular Function, Right | 1 | 2012 | 162 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 142 | 0.020 |
Why?
|
| Swine | 1 | 2012 | 607 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 313 | 0.020 |
Why?
|
| Oxygen | 1 | 2015 | 781 | 0.020 |
Why?
|
| Computer Graphics | 1 | 2010 | 102 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 403 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 2011 | 128 | 0.020 |
Why?
|
| Surgeons | 1 | 2015 | 298 | 0.020 |
Why?
|
| Catheterization | 1 | 2011 | 237 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2474 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 890 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2012 | 446 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 323 | 0.020 |
Why?
|
| Myocardium | 1 | 2012 | 606 | 0.020 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 114 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 2011 | 334 | 0.020 |
Why?
|
| Obesity | 1 | 2015 | 1029 | 0.020 |
Why?
|
| Physicians | 1 | 2016 | 707 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 273 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 712 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 2160 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2010 | 425 | 0.020 |
Why?
|